Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pLX302_FOXA1-V5 Citations (3)

Originally described in: The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis.
Pomerantz MM, Li F, Takeda DY, Lenci R, Chonkar A, Chabot M, Cejas P, Vazquez F, Cook J, Shivdasani RA, Bowden M, Lis R, Hahn WC, Kantoff PW, Brown M, Loda M, Long HW, Freedman ML Nat Genet. 2015 Nov;47(11):1346-51. doi: 10.1038/ng.3419. Epub 2015 Oct 12.
PubMed Journal

Articles Citing pLX302_FOXA1-V5

Direct conversion of porcine primary fibroblasts into hepatocyte-like cells. Fraguas-Eggenschwiler M, Eggenschwiler R, Sollner JH, Cortnumme L, Vondran FWR, Cantz T, Ott M, Niemann H. Sci Rep. 2021 Apr 29;11(1):9334. doi: 10.1038/s41598-021-88727-1. PubMed
Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma. Ferguson LP, Gatchalian J, McDermott ML, Nakamura M, Chambers K, Rajbhandari N, Lytle NK, Rosenthal SB, Hamilton M, Albini S, Wartenberg M, Zlobec I, Galvan JA, Karamitopoulou E, Vavinskaya V, Wascher A, Lowy AM, Schurch CM, Puri PL, Bruneau BG, Hargreaves DC, Reya T. Nat Commun. 2023 Jan 18;14(1):292. doi: 10.1038/s41467-023-35796-7. PubMed
Canonical and Nuclear mTOR Specify Distinct Transcriptional Programs in Androgen-Dependent Prostate Cancer Cells. Chen Y, Han L, Dufour CR, Alfonso A, Giguere V. Mol Cancer Res. 2024 Feb 1;22(2):113-124. doi: 10.1158/1541-7786.MCR-23-0087. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.